Millipore Sigma Vibrant Logo

178462 Apolipoprotein C-II, Human Plasma, Very Low-Density Lipoprotein

View Products on Sigmaaldrich.com
178462
查看价格及供货情况

概述

Replacement Information

价格及供货情况

产品目录编号 库存情况包装 数量 / 包装 价格 数量
178462-50UGCN
正在查询供货情况......
目前缺货
目前缺货
有货 
停产
少量现货
供货情况有待确认
    其余:另行通知
      其余:另行通知
      另行通知
      联系客户服务
      Contact Customer Service

      塑胶安瓿;塑胶针药瓶 50 μg
      正在检索价格......
      无法检索价格。
      最小订购数量为倍数
      Maximum Quantity is
      以订单确认为准 更多信息
      您节约了 ()。
       
      Request Pricing
      Description
      OverviewNative apolipoprotein C-II from human plasma. Found primarily in VLDL and chylomicrons. Functions as a cofactor for lipoprotein lipase. Elevated serum levels of Apo C-II are common in type I, III, IV, and V hyperlipoproteinemia. Low serum concentrations of Apo C-II are indicative of nephrotic syndrome (Tangier’s Disease).
      Catalogue Number178462
      Brand Family Calbiochem®
      SynonymsApo C-II
      References
      ReferencesBrunzell, J.D. 1989. in The Metabolic Basis of Inherited Disease, 6th Edition (Scriver, G.R., ed.) p. 1165, McGraw Hill, New York.
      Le, N.A., et al. 1988. J. Lipid Res. 29, 669.
      Jackson, R.L., and Holdsworth, G. 1986. Methods Enzymol. 128, Chapter 14.
      Product Information
      FormLyophilized
      FormulationLyophilized from 10 mM NH₄HCO₃, pH 7.4.
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥95% by SDS-PAGE
      SourcePrepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      产品目录编号 GTIN
      178462-50UGCN 04055977205107

      Documentation

      Apolipoprotein C-II, Human Plasma, Very Low-Density Lipoprotein MSDS

      职位

      物料安全数据表 (MSDS) 

      Apolipoprotein C-II, Human Plasma, Very Low-Density Lipoprotein 分析证书

      标题批号
      178462

      参考

      参考信息概述
      Brunzell, J.D. 1989. in The Metabolic Basis of Inherited Disease, 6th Edition (Scriver, G.R., ed.) p. 1165, McGraw Hill, New York.
      Le, N.A., et al. 1988. J. Lipid Res. 29, 669.
      Jackson, R.L., and Holdsworth, G. 1986. Methods Enzymol. 128, Chapter 14.
      数据表

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision15-April-2008 RFH
      SynonymsApo C-II
      DescriptionNative apolipoprotein C-II from human plasma. Found primarily in VLDL and chylomicrons. Functions as a cofactor of lipoprotein lipase. Elevated serum levels of Apo C-II are often present in type I, III, IV and V hyperlipoproteinemia. Low serum concentrations of Apo C-II are indicative of nephrotic syndrome (Tangier disease).
      FormLyophilized
      FormulationLyophilized from 10 mM NH₄HCO₃, pH 7.4.
      SourcePrepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
      Purity≥95% by SDS-PAGE
      SolubilityH₂O. Please refer to vial label for lot-specific volume prior to lyophilization.
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesBrunzell, J.D. 1989. in The Metabolic Basis of Inherited Disease, 6th Edition (Scriver, G.R., ed.) p. 1165, McGraw Hill, New York.
      Le, N.A., et al. 1988. J. Lipid Res. 29, 669.
      Jackson, R.L., and Holdsworth, G. 1986. Methods Enzymol. 128, Chapter 14.